Discovery of 5‑Chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1H)‑one (BMS-903452), an Antidiabetic Clinical Candidate Targeting GPR119

Overview of attention for article published in Journal of Medicinal Chemistry, September 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 43 Dimensions

Readers on

mendeley: 38 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3…

Grant US-12037328-B2

United States of America

Compounds containing polysubstituted benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide…

Grant US-11358956-B2

United States of America

Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3…

Grant US-10906894-B2

United States of America

Pyrimidine derivatives as anti-diabetic agents

Grant US-10702525-B1

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.